AMIX · XBRL financial data

Autonomix Medical financial statements, every quarter

The same tables from 11 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (AMIX's year ends in late March)

In thousands of dollars	Q3 FY24Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY24Jun 30, 2024	Q2 FY24†Sep 30, 2024	Q3 FY25Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY26Jun 30, 2025	Q2 FY26Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY27Jun 30, 2026
Revenue	0	0*	0	0	0	0*	0	0	0	0*	0
Research and development	601	841*	954	1,174	1,044	1,553*	1,593	2,367	1,724	1,460*	1,515
General and administrative	2,323	1,575*	1,799	1,662	1,703	1,699*	1,828	5,167	1,619	1,277*	1,255
Total operating expenses	2,924	2,416*	2,753	2,836	2,747	3,252*	3,421	7,534	3,343	2,737*	2,770
Operating income (loss)	(2,924)	(2,416)*	(2,753)	(2,836)	(2,747)	(3,252)*	(3,421)	(7,534)	(3,343)	(2,737)*	(2,770)
Interest income	23	80*	95	72	80	107*	84	83	82	71*	42
Interest expense	33	46*	41	43	45	46*	0	0	0	0*	—
Income tax expense (benefit)	0	0*	0	0	0	0*	0	0	0	0*	0
Net income (loss)	(3,113)	(15,426)	(2,699)	(2,807)	(2,712)	(11,410)	(3,337)	(7,451)	(3,261)	(2,666)*	(2,728)
Earnings per share, basic‡ USD per share	(4.83)	—	(2.94)	(51.87)	(30.66)	—	(22.47)	(28.98)	(7.56)	—	(5.02)
Earnings per share, diluted‡ USD per share	(4.83)	—	—	—	—	—	—	—	—	—	—
Weighted average shares, basic‡ thousands of shares	657	—	900	54	88	—	148	258	426	—	544
Weighted average shares, diluted‡ thousands of shares	657	—	—	—	—	—	—	—	—	—	—

‡ Per-share figures and share counts are adjusted for the 1-for-21 stock split (June 2026); filings made before it reported them unadjusted.
† Share count changed about 1/20 in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (AMIX's year ends in late March)

In thousands of dollars	Q3 FY24Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY24Jun 30, 2024	Q2 FY24†Sep 30, 2024	Q3 FY25Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY26Jun 30, 2025	Q2 FY26Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY27Jun 30, 2026
Cash and cash equivalents	1,218	8,608	6,751	5,155	11,823	9,136	8,589	7,477	9,934	7,004	3,460
Total current assets	1,685	9,391	7,076	5,354	11,932	9,609	8,978	7,893	10,191	7,581	3,964
Property and equipment, net	14	16	19	17	20	21	19	16	20	19	16
Total assets	1,809	9,407	7,095	5,371	11,952	9,806	8,997	7,932	10,211	7,600	3,980
Accounts payable	663	492	287	574	232	676	815	842	714	700	371
Accrued liabilities	310	285	476	683	881	1,031	1,150	645	936	1,005	447
Total current liabilities	973	777	763	1,257	2,245	1,707	1,965	1,487	1,650	1,705	818
Total liabilities	7,404	1,779	1,806	2,343	2,245	1,707	1,965	1,487	1,650	1,705	818
Accumulated deficit	(33,561)	(38,969)	(41,668)	(44,475)	(47,187)	(50,379)	(53,716)	(61,167)	(64,427)	(67,094)	(69,822)
Total stockholders' equity	(5,595)	7,628	5,289	3,028	9,707	8,099	7,032	6,445	8,561	5,895	3,162
Total liabilities and equity	1,809	9,407	7,095	5,371	11,952	9,806	8,997	7,932	10,211	7,600	3,980
Common shares outstanding (cover page)‡ thousands of shares	895	897	1,097	55	117	132	245	328	543	543	971

‡ Per-share figures and share counts are adjusted for the 1-for-21 stock split (June 2026); filings made before it reported them unadjusted.
† Share count changed about 1/20 in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (AMIX's year ends in late March)

In thousands of dollars	Q3 FY24Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY24Jun 30, 2024	Q2 FY24†Sep 30, 2024	Q3 FY25Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY26Jun 30, 2025	Q2 FY26Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY27Jun 30, 2026
Net income (loss)	(3,113)	(15,426)	(2,699)	(2,807)	(2,712)	(11,410)	(3,337)	(7,451)	(3,261)	(2,666)*	(2,728)
Stock-based compensation	212*	618	360	445*	418*	1,628	388	138*	2*	1*	2
Depreciation and amortization	35*	81	43	45*	47*	183	3	2*	4*	3*	3
Net cash from operating activities	(2,556)*	(6,648)	(1,852)	(1,596)*	(2,301)*	(8,258)	(2,604)	(3,817)*	(2,969)*	(2,892)*	(3,544)
Purchases of property and equipment	16*	19	5	0*	5*	14	0	0*	7*	3*	—
Net cash from investing activities	(16)*	(19)	(5)	0*	(5)*	(14)	0	0*	(7)*	(3)*	—
Proceeds from issuing common stock	0*	0*	0	0*	0*	2*	2,121	—	—	year only	0
Net cash from financing activities	1,645*	14,410	0	0*	8,974*	8,800	2,057	2,705*	5,433*	(35)*	0
Net change in cash	(927)*	7,743	(1,857)	(1,596)*	6,668*	528	(547)	(1,112)*	2,457*	(2,930)*	(3,544)

† Share count changed about 1/20 in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Autonomix Medical	3,460	0	(3,544)	971,043	1.0 quarters	Q1 FY27 10-QJun 30, 2026
Sonoma Pharmaceuticals	5,338	6,406	(649)	4.8M	8.2 quarters	Q1 FY27 10-QJun 30, 2026
Odyssey Health	122	not reported	(160)*	110.2M	0.8 quarters	Q4 FY26 10-KJul 31, 2026
Family Office of America	637	533	149*	30.8M	—	Q2 FY26 10-QJun 30, 2026
Adm Tronics Unlimited	223	not reported	(33)	67.6M	6.8 quarters	Q1 FY26 10-QJun 30, 2026
Aethlon Medical	4,934	not reported	(1,897)	711,136	2.6 quarters	Q1 FY27 10-QJun 30, 2026
Bone Biologics	6,088	not reported	(532)*	3.4M	9.8 quarters	Q3 FY26 10-QSep 30, 2026
SeaStar Medical Holding	6,959	615	(2,994)*	4.4M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
ENvue Medical	1,084	239	(2,691)*	11.1M	0.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.